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Background/aim: Pulmonary arteriovenous malformations (PAVMs) are direct communications between the branches of pulmonary
arteries and veins. This study evaluates surgically treated cases of pulmonary arteriovenous malformations.
Materials and methods: We retrospectively examined 41 cases of PAVM that were operated in our clinic between 1995 and 2012. We
obtained the clinical, radiological, and surgical data of the patients from their files.
Results: The 41 cases comprised 27 males and 14 females. Their mean age at diagnosis was 39.8 years (range: 9–71). The symptoms
were hemoptysis in 28 cases, dyspnea in five, cough in three, and epistaxis in two; three patients were asymptomatic. Twenty-three
right and 19 left posterolateral thoracotomies were performed, including one case which was operated bilaterally. Lower lobectomy was
performed in 17 patients, lower lobectomy and lingulectomy in two, upper lobectomy in ten, middle lobectomy in two, segmentectomy
in seven, and wedge resection in four. Postoperative histopathology was arteriovenous malformation in all cases.
Conclusion: PAVMs are rare clinical conditions. Surgery remains the first choice when embolization treatment cannot be performed or
is not successful, in symptomatic and complicated patients with PAVM, and/or in cases where the PAVM diagnosis cannot be established.
Key words: Arteriovenous malformation, lung, surgery

1. Introduction
Pulmonary arteriovenous malformations (PAVMs) are
direct communications between the branches of pulmonary
arteries and veins, without an intervening pulmonary bed
(1). In 1897, Churton first described PAVM in a 12-yearold boy (2). PAVM has been variously called pulmonary
arteriovenous fistula, aneurysm, pulmonary angioma,
arteriovenous angiomatosis, cavernous hemangiomas,
and telangiectasia. PAVM is the preferred term, however,
as it represents a developmental anomaly (1,3). Although
it is the most common anomaly of the pulmonary vascular
bed, PAVM remains an extremely rare clinical formation.
The incidence in the general population is still not fully
known, but it is estimated at 2–3 cases per 100,000.
PAVMs are detected most commonly in the fifth and sixth
decades; 10% are seen in infants and children (1). Patients
with PAVM may be asymptomatic or may present with
dyspnea, paradoxical thromboembolism, brain abscess,
or massive hemoptysis. While more than 80% of PAVM
cases are congenital, 47%–80% are also associated with
* Correspondence: ebru.sayilir@gmail.com

hereditary hemorrhagic telangiectasia (HHT) or Rendu–
Osler–Weber syndrome (1,3).
In 1940, Shenstone performed what is considered to
be the first excisional procedure, a pneumonectomy for
a large, centrally located lesion, which was reported by
Hepburn and Dauphinee in 1942 (4). Since then, although
surgery has been the only treatment approach for PAVM,
following a report by Taylor et al. in 1978 of successful
percutaneous transcatheter embolization in one case,
embolization has gradually replaced surgery (1,3). Herein,
we present a review of PAVM patients that underwent
surgery in our clinic.
2. Materials and methods
We retrospectively reviewed the pathological records of
surgical procedures performed in our department from
1995 to 2012, and we identified 41 patients with PAVM.
Those cases were reviewed for demographic data, clinical
presentations, diagnostic investigations, operative procedures,
histopathological features, morbidity, and mortality.
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3. Results
Of the 41 patients who met our inclusion criteria, 27 were
male and 14 female, with a mean age at diagnosis of 39.8 years
(range: 9–71 years). Only one patient was under 18 years (9
years old, male). While 38 cases (92.6%) were symptomatic,
only three cases (7.3%) were asymptomatic, and the
lesions were detected incidentally on chest radiography.
The symptoms were hemoptysis in 28 patients (68.3%),
shortness of breath in five (12.1%), cough in three (7.3%),
and recurrent epistaxis in two (4.8%). Patients presenting
with hemoptysis had a mean age of 40.5 years (range:
22–67 years). Eleven of these patients had life-threatening
massive hemoptysis; one of them was in the 22nd week
of gestation and one other patient, who presented with
recurrent hemoptysis, had a history of hemoptysis during
pregnancy 11 years ago. Three patients who had received
transcatheter coil embolization had recurrent hemoptysis at
1 year, 6 months, and 2 months of follow-up, respectively.
Two patients had petechiae of the lingual and labial mucosa
and telangiectasia in various parts of the body, four had
digital clubbing, two had cyanosis, and one had mitral
valve prolapse and pectus excavatum. Systolic murmur
was detected in the thorax during inspiration in only three

patients. In the family history of two patients with HHT,
13 and 11 family members, respectively, had similar lesions
and suffered from recurrent epistaxis or hemoptysis.
Routine laboratory tests such as complete blood count
and biochemical parameters were within normal limits.
In two patients, preoperative arterial oxygen saturations
were 74% and 77% on room air, and they increased to 92%
and 98% postoperatively. In all cases, chest X-rays and
chest computed tomography (CT) images were taken. CT
imaging was contrast-enhanced in all cases except one. In
the case files of four patients, there were reports of CTs,
but the images were not available. All radiographs were
reevaluated retrospectively by a radiologist. Radiological
findings are shown in Table 1. With the results of these
findings, PAVM was not suggested in 62.1% (n = 23) of
the cases, findings were compatible with PAVM in 35.1%
(n = 13) of the cases (Figures 1 and 2), and PAVM was
suspected in one patient (representing 2.7%). Preoperative
angiography was performed in six patients and three of
them were detected as having PAVM. These patients were
ineligible for transcatheter embolization. Hemothorax was
detected in one of the patients with pleural effusion and an
invasive procedure was not considered.

Table 1. Radiological findings.
Chest X-rays
Pathological findings 75.6%
10% were consistent with AVM
Computed tomography
Sizes of the measurable lesions: 1.5–9 cm (mean: 3.8 cm)
Signs

Number of patients (n)

%

1. Signs of lesions

37

100%

Limited lesions

19

51.3%

Possible limited lesions

16

43.2%

Obliterating air-column lesions in centrum

2

5.5%

2. Collapsed and consolidated

18

48.6%

3. Parenchymal hemorrhage

23

62.1%

4. Cavitation

5

13.5%

5. Bronchiectasis

13

35%

6. Pleural pathology

8

21.6%

7. Malignant mass lesion

11

29.7%

4

10.5%

Positron emission tomography
Suspected malignancy
(Standard uptake maximum values: 2.97–15.03)
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Figure 1. Hyperdense tubulonodular formations compatible
with subcarinal, paraesophageal, and right infrahilar enlarged
vascular structures.
Bronchoscopy was performed in all cases. Rigid
bronchoscopy was performed in the operating room
on the patients operated on emergently, due to massive
hemoptysis. Fiberoptic bronchoscopy was performed
electively in the other cases. In 18 cases, there was active
hemorrhage: hematoma in four, inactive hemorrhage
with evidence of previous bleeding in four, endobronchial
lesion in three, telangiectasia in two, mucosal irregularity
in one, and vascular fistula in one. The other cases revealed
normal findings. The biopsy results of the patients with
endobronchial lesion indicated squamous metaplasia in
one.
Although there were no neurological symptoms in 11
cases, contrast-enhanced brain CT or magnetic resonance
imaging was performed. PAVM was observed in only two
patients. The neurology clinic had followed these patients
because they were asymptomatic.
Transthoracic needle biopsy was performed in three
patients with suspected malignancy and pathology was
reported nondiagnostic.
Cases followed with a presumptive diagnosis of
PAVM were referred to the hematology and dermatology
departments to investigate HHT. In the dermatological
consultation, two patients with skin manifestations were
evaluated as having HHT. While the eye examinations were
normal in these cases, ear, nose, and throat examinations
revealed telangiectasia on the nasopharynx, larynx, oral
mucosa, and nasal mucosa. One of the patients suffered
recurrent nose bleeding and the other suffered from
coughing. In both cases, there was clubbing of the fingers.
Chest X-rays showed that one had a lesion on the right-

Figure 2. A, B) Dense contrasted tubular and nodular enhancing
lesions consistent with typical PAVM; right lower lobe.

upper lobe and the other had bilateral lower-lobe lesions
that were compatible with PAVM. Echocardiography
indicated increased left ventricular diameter and volume,
enlarged left ventricle, and pulmonary artery pressure of 45
mmHg in one case. Doppler ultrasonography of the liver
indicated hepatic artery dilatation (10 mm) in one patient.
The patient consulted with gastroenterology and followup was recommended. The patients who were diagnosed
with PAVM via pulmonary angiography were ineligible for
embolization procedure in another center.
Surgical resection alone was carried out for all
patients. Emergency surgeries were performed in 11
cases; elective surgeries were performed when optimum
conditions were established in the other cases. Including
one case of bilateral procedure, 41 patients underwent
42 posterolateral thoracotomies (one rethoracotomy).
Selective double-lumen intubation was performed in all
cases. Table 2 shows the surgical procedures.
The macroscopic appearance of the lesions, in addition
to pulsatile solitary lesions, indicated intralesional
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Table 2. Surgical procedures.
Right

Left

Total

L

S

W

L

S

W

P

Upper lobe lesion

5

1

1

5

4

1

1

Lower lobe lesion

11

1

1

7*

Middle lobe lesion

2

1

1

18
21
3

L: Lobectomy, S:segmentectomy, W:wedge resection, P: pneumonectomy,
*:added lingulectomy.

hematoma in nine cases. The diameter of the lesions ranged
from microscopic appearance to 9 cm. Histopathological
examination revealed dense vascular structure in all cases,
as well as parenchymal bleeding in 19 cases, intralesional
hemorrhage and hematoma in nine cases, and bleeding
accompanied by bronchiectasis in six cases.
One patient developed PAVM 15 years after hydatid
cyst surgery, and six patients had lesions accompanied
by bronchiectasis, suggesting that, in these cases, the
lesions were secondary to these diseases. Therefore, PAVM
was secondary to another disease in seven patients and
congenital in 34 cases.
The postoperative follow-up period ranged from
6 months to 17 years (mean: 6 years). In the early
postoperative period, left hemiplegia developed in one
patient who had had a lower lobectomy. During follow
up of this patient, a completion pneumonectomy was
performed following consolidation of the upper lobe on
radiologically. Myoplasty was performed in one patient
who developed a bronchopleural fistula after postoperative
empyema. One patient developed deep vein thrombosis,
and one patient had recurrent hemoptysis. The source of
bleeding could not be determined by angiography, but the
hemoptysis improved with medical treatment. Five cases
were lost to follow-up and all the other patients remained
healthy.
4. Discussion
PAVM is a low-pressure, abnormal, vascular connection
composed of an afferent pulmonary artery, distended
efferent pulmonary veins, and an intervening thin-walled
aneurysmal sac or tangle of dilated tortuous vascular
channels. The PAVM may lie deep within the pulmonary
parenchyma or immediately under the pleura (5). The
incidence of PAVM in the general population is still not
fully known, but is estimated to be 2–3 per 100,000 (1). In
an autopsy study in 1953 at Johns Hopkins Hospital, only
three cases of PAVM were detected in 15,000 consecutive
autopsies. However, it was noted by the same investigators
that small PAVMs could easily be missed in routine

164

autopsy (3). Nakayama et al. identified eight patients with
PAVM among 21,235 participants by low-dose thorax
CT (6). More than 500 cases have been reported in the
literature (1). At our clinic, 15,914 thoracic surgeries were
performed between 1995 and 2012; therefore, PAVM
frequency among thoracic surgeries was 26 in 10,000. Our
hospital is a referral center for pulmonary disease and chest
surgery patients, so this is a selected group of patients.
Females are affected twice as often as males, but there
is a male predominance in newborns. Although PAVM
occurs at any age, it is more frequently seen in the fifth
and sixth decades. Around 10% of cases are identified in
infancy or childhood (1,3). Contrary to the literature, our
study showed male dominance, with a F/M ratio of 1:1.93.
Only one of our patients (a 9-year-old male) was less than
18 years. The mean age of the patients was 39.8 years.
The etiology and natural course of PAVM is unknown.
These lesions are considered to be congenital and, rarely,
may be viewed as secondary to cases such as cardiac
surgery (Glenn or Fontan procedures), hepatic cirrhosis,
infections, amyloidosis, mitral stenosis, chest trauma,
metastatic carcinoma, previous thoracic surgery, and
bronchiectasis. Pregnancy is also associated with growth
and increased complications of PAVM (1,7,8). It is known
that there is a relationship between PAVM and HHT.
Recent studies on the genetics of HHT have shown that
genetic transitions observed in HHT may be applicable to
PAVM etiology (3,5). In our study, PAVM was secondary
in seven cases and congenital in 34 cases.
More than half of patients with PAVM are
asymptomatic, and lesions are often detected by routine
chest X-ray (7). In general, common symptoms are fatigue,
dyspnea on exertion, cough, chest pain, hemoptysis, and
recurrent epistaxis attacks. Although dyspnea is the most
common symptom, it may not be seen until partial oxygen
pressure drops to less than 60 mmHg (1,5). Risk factors
are young age, lesions larger than 2 cm, and HHT disease
(1,7). Epistaxis is the most common symptom in patients
with HHT, characterized by spontaneous development
or emergence with minor trauma (9). Hemoptysis rarely
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occurs as a result of intrabronchial rupture or bleeding
bronchial telangiectasis. Massive hemoptysis and massive
hemothorax from rupture of PAVM into the pleural space
have been reported, with fatal outcomes (10). Ference et al.
reported an 8% incidence of fatal or massive hemoptysis or
hemothorax (11). Pregnancy may be a risk for hemoptysis
in patients with PAVM (1,10). Three patients (7.3%) in
our series were asymptomatic. The most common reason
patients seek medical attention is hemoptysis, which
occurred in 68.3% of cases in this study; of these, 26.8%
had life-threatening massive hemoptysis. One patient
had hemoptysis while she was pregnant, two patients had
epistaxis, and one patient had hemothorax.
The majority of patients (75%) show no abnormal
physical findings. Physical examination can reveal
cyanosis, anemia, telangiectasia, clubbed fingers, and
systolic murmur heard in the chest. The classic triad of
PAVM is cyanosis–polycythemia–clubbed fingers, but
these were observed in only 20% of the cases. The presence
of cyanosis suggests that at least 25%–30% of the blood in
pulmonary circulation goes with right-to-left shunting to
the left atrium without oxygenation (1,12). In patients with
HHT, the most common and often the only finding is skin
telangiectasis (3). According to the International Clinical
Diagnostics (Curaçao) Criteria, diagnosis of the disease is
made via three or more of following criteria: self-recurrent
bleeding episodes, mucocutaneous telangiectasis, visceral
PAVMs, and first-degree relatives diagnosed with HHT
(5,13). A Mayo Clinic study reported cyanosis, clubbing,
and murmur incident rates of 29%, 19%, and 34%,
respectively (5); in our study, these rates were 4.8%,
9.7%, and 7.3%, respectively. Only two of our cases were
accompanied by HHT.
PAVMs are serpiginous-like masses related with vessels
or nodular masses with clear margins on thoracic CT.
The classic view of PAVM on chest radiographs is in the
form of round or oval lesions of equal density, frequently
lobulated but well circumscribed, mostly occurring in
the lower lobes, and 1–5 cm in diameter. Lesions are
the only indication in two-thirds of cases. In plain chest
X-rays, PAVM may manifest in the form of the spread
of hemorrhaging to parenchyma, or atelectasis due to
bronchus compression. Microvascular telangiectasis can
create a normal chest X-ray, or pulmonary vascular signs
may increase vaguely (2,7,12). In dynamic examination,
PAVMs typically enhanced contrast after the right
ventricle or pulmonary artery, before the left atrium and
ventricle. Sensitivity and specificity of PAVM detection
in contrast-enhanced CT has been reported as 83% and
78%, respectively, which compares favorably with digital

subtraction pulmonary angiography results of 70% and
100% (10). Remy et al. reported that the CT rate of PAVM
diagnosis was 98.2%, and that of angiography was 59.6%
(14). Contrast-enhanced chest CT can view multiple small
PAVMs, whereas pulmonary angiography sometimes
cannot (1). In our study, radiological investigations of
patients who were surgically diagnosed with PAVM were
reevaluated for this study. Unlike other studies, 62.1% of
the lesions were not compatible with PAVM; they were
mostly consolidation of bleeding and of a ground-glass
appearance.
The current preferred treatment for the majority of
patients with PAVMs is percutaneous embolotherapy
using coils or balloons (15). In recent years, Amplatzer
vascular plugs have also been used. Embolization is less
invasive than surgery, and it is an easily applicable method.
The success rate has been reported as 98% (16). Surgical
approaches include wedge resection, segmentectomy,
lobectomy, and pneumonectomy. In our study, surgery
was preferred in cases where treatment of the embolism
was unsuccessful or not possible, in patients with
symptomatic and complicated PAVM, and/or when a
differential diagnosis of PAVM was not possible. The
surgical approach is anatomical resection in our clinic.
The parenchyma-sparing approach has been preferred in
small, peripherally located lesions in recent years and was
performed in 26% of the operations in this study.
Approximately 20% of untreated patients die due
to complications (5). The most frequently reported
complications relate to the central nervous system and are
seen in 30% of patients. Complications were often seen
in patients whose feeding artery was more than 3 mm in
diameter (17). Hemoptysis and hemothorax are rare but
life-threatening complications. Stringer et al. reported that
30 of 140 patients with PAVM had serious complications
or died. Dalton et al. reported that nine patients developed
intrapleural rupture (12). The mortality rate has been
reported as 50% in untreated cases, compared with less
than 3% in treated cases (1,3). Neurological complications
were not observed in this study, but 70.7% of the
patients were admitted to our clinic with complications.
Postoperative complications were seen in three cases, and
mortality was not reported. Five cases were lost to followup and the other patients remain healthy.
In conclusion, PAVMs are rare clinical conditions.
Surgery remains the first choice in cases where treatment
of the embolization cannot be performed or has not been
successful, in symptomatic and complicated patients with
PAVM, and/or cases where the PAVM diagnosis cannot be
established.
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